Essais liés3clinical trials
VilleFoxboroughlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07816367

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Elismetrep Migraine Phase 3 NCT07816367 A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine RECRUITING
EVO756, Dose 1 Migraine Phase 2 NCT07616128 Study of EVO756 in Adults With Migraine RECRUITING
PIPE-307 Dose A SEP Phase 2 NCT06083753 VISTA — Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis COMPLETED